Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page
- Check6 days agoChange DetectedPage revision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedMinor UI update: Revision v3.4.2 replaces v3.4.1 in the page footer, with no changes to study content, eligibility criteria, or results data — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no user-facing changes to study details or page content.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded a glossary display and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus Revision: v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page shows an updated revision label: v3.3.4 replacing v3.3.3. No changes to the study details or content are evident.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations section updated with many new sites across the US, Canada, and other regions, and some previously listed locations were removed (Revision: v3.3.3).SummaryDifference2%

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.